Revvity | PKI - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Agilent USD 7.12B 214M 2026-03
Align Technology USD 4.23B 83.03M 2026-06
Bio Techne USD 2.09B 74.32M 2026-03
Bio-Rad Laboratories USD 7.17B 322.6M 2026-06
Bruker USD 2.44B 67M 2026-06
Celltrion KRW 434.82B 1.14B 2026-03
Charles River Laboratories USD 2.84B 59.06M 2026-06
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Danaher USD 52.58B 368M 2026-06
Dentsply International USD 1.35B 33M 2026-06
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 1.17B 29.29M 2026-06
Divis Laboratories Ltd INR 167.61B 13.48B 2026-03
Edwards Lifesciences USD 10.62B 290.5M 2026-06
Illumina USD 2.84B 162M 2026-06
Intuitive Surgical USD 18.17B 693.9M 2026-06
IQVIA Holdings USD 6.17B 50M 2026-06
Kangmei Pharma CNY 7.31B 84.82M 2026-03
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Laboratory Of America USD 8.61B 121.8M 2026-06
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Mesa Laboratories USD 186.69M 8.22M 2025-12
Mettler Toledo International USD 12.82M 54.71M 2026-06
Myriad Genetics USD 303.9M 33.5M 2026-06
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
OraSure Technologies USD 317.78M 4.45M 2026-06
Organigram Holdings CAD 371.81M 2.36M 2026-03
Ovoca Bio EUR 780K 485K 2025-12
Pacific Biosciences Of California USD -33.21M 35.58M 2026-06
Pharma Mar EUR 250.77M 1.1M 2026-06
Qiagen NV USD 3.36B 26.03M 2026-06
Quest Diagnostics USD 7.52B 150M 2026-06
Quidel USD 1.85B 69.1M 2026-03
Repligen USD 2.11B 6.57M 2026-06
Revvity USD 7.18B 67.62M 2026-03
Sartorius EUR 2.82B 96.3M 2026-06
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Tilray USD 1.58B 39.08M 2025-09
Waters USD 15.29B 12.73B 2026-03
Zealand Pharma A/S 14.47B 361.61M 2026-03
Zz Pientze Pharmaceu CNY 15.21B 740.32M 2026-03